Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic…

Overview of attention for article published in BMC Cancer, April 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 4 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 66 Mendeley

Summary Patents Wikipedia

So far, Altmetric has seen 4 patents that reference this research output.

Combination therapy for cancer treatment

Grant US-11844795-B2

United States of America

Methods for treating metastatic pancreatic cancer using combination therapies comprising…

Grant US-11344552-B2

United States of America

Nanoliposomal irinotecan for use in treating small cell lung cancer

Grant US-11318131-B2

United States of America

Methods for treating pancreatic cancer using combination therapies comprising liposomal…

Grant US-10980795-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.